ProgynyPGNY
About: Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Employees: 566
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
43% more call options, than puts
Call options by funds: $3.47M | Put options by funds: $2.43M
1% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 95
1.54% less ownership
Funds ownership: 95.53% [Q2] → 93.99% (-1.54%) [Q3]
13% less funds holding
Funds holding: 321 [Q2] → 278 (-43) [Q3]
41% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 104
47% less capital invested
Capital invested by funds: $2.6B [Q2] → $1.38B (-$1.22B) [Q3]
57% less funds holding in top 10
Funds holding in top 10: 7 [Q2] → 3 (-4) [Q3]
Research analyst outlook
13 Wall Street Analysts provided 1 year price targets over the past 3 months
13 analyst ratings
Barclays Sarah James 43% 1-year accuracy 60 / 141 met price target | 22%upside $17 | Overweight Maintained | 14 Nov 2024 |
B of A Securities Michael Cherny 47% 1-year accuracy 15 / 32 met price target | 51%upside $21 | Buy Maintained | 13 Nov 2024 |
Canaccord Genuity Richard Close 50% 1-year accuracy 15 / 30 met price target | 22%upside $17 | Hold Maintained | 13 Nov 2024 |
Truist Securities Jailendra Singh 18% 1-year accuracy 6 / 34 met price target | 37%upside $19 | Hold Downgraded | 13 Nov 2024 |
Cantor Fitzgerald Sarah James 43% 1-year accuracy 60 / 141 met price target | 80%upside $25 | Overweight Reiterated | 1 Oct 2024 |
Financial journalist opinion
Based on 21 articles about PGNY published over the past 30 days
